Frontiers of COVID-19: Scientific and Clinical Aspects of the Novel Coronavirus 2019
Editat de Sasan Adibi, Paul Griffin, Melvin Sanicas, Maryam Rashidi, Francesco Lanfranchien Limba Engleză Paperback – 10 sep 2023
Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 748.06 lei 38-44 zile | |
| Springer International Publishing – 10 sep 2023 | 748.06 lei 38-44 zile | |
| Hardback (1) | 1104.84 lei 22-36 zile | |
| Springer International Publishing – 9 sep 2022 | 1104.84 lei 22-36 zile |
Preț: 748.06 lei
Preț vechi: 787.44 lei
-5% Nou
Puncte Express: 1122
Preț estimativ în valută:
143.16€ • 148.71$ • 118.92£
143.16€ • 148.71$ • 118.92£
Carte tipărită la comandă
Livrare economică 29 ianuarie-04 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783031080470
ISBN-10: 3031080475
Pagini: 664
Ilustrații: XX, 664 p. 126 illus., 93 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3031080475
Pagini: 664
Ilustrații: XX, 664 p. 126 illus., 93 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Section I. History, Epidemiologic Background and Pathogenesis of Coronavirus.- Chapter 01: Surfaces as a source for SARS-CoV-2 transmission.- Chapter 02: Humoral immune response in SARS-CoV-2 infection & its therapeutic relevance.- Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system.- Chapter 04: Genetics and Biological characteristics of SARS-CoV-2.- Chapter 05: COVID-19 impact on host at pathophysiological and cellular level.- Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design.- Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies.- Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2.- Chapter 09: Emergence of COVID-19 variants and its global impact.- Section II. Clinical Observations.- Chapter 10: Psychological Impacts of the COVID-19 Pandemic.- Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications.- Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19.- Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic.- Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines.- Chapter 15: Post COVID-19 conditions-the new challenge to mankind.- Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials.- Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours.- Chapter 18: Neurological Complications of COVID-19.- Chapter 19: The Impact of Covid-19 on Surgical Disease.- Section III. Interventions and Treatments.- Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective.- Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19.- Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19.- Section IV. Current Trends and Future Directions.- Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy.- Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges.- Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms.- Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination.- Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !?.- Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021.- Chapter 29: The Global Evolution of Clinical Practice During a Pandemic.- Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19.- Chapter 31. The road ahead
Notă biografică
Sasan Adibi, PhD, Senior Member, IEEE
School of IT
Deakin University
Melbourne, Australia
A/Prof Paul Griffin
B.Sc. (Hons), MBBS, FRACP, FRCPA, FACTM
School of Medicine, University of Queensland, Queensland, Australia
Department of Infectious Diseases, Mater Health, Queensland, Australia
Melvin Sanicas, MD, MSc, FRSPH, FRSA
Senior Medical Director, Global Medical Affairs
Clover Biopharmaceuticals
Zurich, Switzerland
Maryam Rashidi, MD, PhD
Senior Postdoctoral Researcher
Immunology and Inflammation
Walter & Eliza Hall Institute of Medical Research (WEHI)
Melbourne, Australia
Francesco Lanfranchi, MD
Nuclear Medicine Unit
Department of Health Sciences (DISSAL) University of Genoa
Genoa, Italy
School of IT
Deakin University
Melbourne, Australia
A/Prof Paul Griffin
B.Sc. (Hons), MBBS, FRACP, FRCPA, FACTM
School of Medicine, University of Queensland, Queensland, Australia
Department of Infectious Diseases, Mater Health, Queensland, Australia
Melvin Sanicas, MD, MSc, FRSPH, FRSA
Senior Medical Director, Global Medical Affairs
Clover Biopharmaceuticals
Zurich, Switzerland
Maryam Rashidi, MD, PhD
Senior Postdoctoral Researcher
Immunology and Inflammation
Walter & Eliza Hall Institute of Medical Research (WEHI)
Melbourne, Australia
Francesco Lanfranchi, MD
Nuclear Medicine Unit
Department of Health Sciences (DISSAL) University of Genoa
Genoa, Italy
Textul de pe ultima copertă
This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of “herd immunity” and explore the current vaccine trials taking place in different countries. This comprehensive book will illuminate recent advances regarding COVID-19 and offer a possible roadmap on how to move forward.
Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level.
Caracteristici
Features a strong and international team of experts Explores lessons learned and potential roadmaps to curbing future outbreaks Discusses important issues on possible treatments and vaccines